Evaluation of the effect of Virechan and Shilajit in comparision to Thyroxine Sodium in the management of Hypothyroidism

Evaluation of the effect of Virechan and Shilajit in comparision to Thyroxine Sodium in the management of Hypothyroidism. - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/062170

Enrollment

Registered

2024-01-31

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Newly diagnosed case of Hypothyroidism. Patients age between 25 years to 45 years. Patients those fit for Virechan Karma.

Exclusion criteria

Exclusion criteria: All complicated cases of Hypothyroidism, myxedema, severe mental illness, thyroid cancer etc. and other disease associated with endocrine imbalance. Patients having chronic systemic illness. Congenital hypothyroidism Pregnant women and Lactating Mother. Patients having undergone thyroid surgery. Patients those unfit for Virechan Karma.

Design outcomes

Primary

Measure	Time frame
It is expected that at the end of the study we would be able to demonstrate the effects of virechan karma and shudhh shilajit in the management of hypothyroidism. It is further expected that this study would be able to provide comparative efficacy between the trialed treatment to that of standard controle ie. Thyroxine sodium.Timepoint: 45 Days	—

Secondary

Measure	Time frame
Thyroxin Sodium is more effective than Virechana Karma And Shuddha ShilajitTimepoint: 45 Days	—

Countries

India

Contacts

Public ContactDr Sonika Solanki

Pandit Khushilal Sharma Government Ayurveda college and Institute Bhopal

preetichaturvedi227@gmail.com7999013557

Outcome results